A.J. Camm-rekin lankidetzan egindako argitalpenak (8)

2018

  1. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)

    American Journal of Cardiology, Vol. 122, Núm. 4, pp. 578-583

2010

  1. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey

    Chest, Vol. 138, Núm. 5, pp. 1093-1100

  2. Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis

    Journal of the American College of Cardiology, Vol. 55, Núm. 8, pp. 725-731

  3. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation

    Chest, Vol. 137, Núm. 2, pp. 263-272

2008

  1. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: Follow-up of the Euro Heart Survey on Atrial Fibrillation

    European Heart Journal, Vol. 29, Núm. 9, pp. 1181-1189

2007

  1. Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation

    Journal of the American College of Cardiology, Vol. 49, Núm. 5, pp. 572-577

2006

  1. Antithrombotic treatment in real-life atrial fibrillation patients: A report from the Euro Heart Survey on Atrial Fibrillation

    European Heart Journal, Vol. 27, Núm. 24, pp. 3018-3026

2005

  1. Atrial fibrillation management: A prospective survey in ESC Member Countries - The Euro Heart Survey on atrial fibrillation

    European Heart Journal, Vol. 26, Núm. 22, pp. 2422-2434